Viewing Study NCT01239134


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2025-12-28 @ 7:41 PM
Study NCT ID: NCT01239134
Status: COMPLETED
Last Update Posted: 2025-08-03
First Post: 2010-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors
Sponsor: Leap Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module